HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing ...

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

A study demonstrates how heart ... Food Insecurity Today, Heart Disease Tomorrow? Mar. 12, 2025 — Struggling to afford food today could mean heart problems tomorrow. Young adults experiencing ...

Daniel Cooper, assistant director for blood donation operations, said: “Thanks to our amazing blood and plasma donors in ...

Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results on track for 2H’25Phase 3 CAPTIVATE trial of ...

NHS patients are now receiving lifesaving medicine made from the blood plasma of Berkshire donors. This marks the first time in 25 years that plasma is being used to create medicines for NHS patients, ...

Treatments, such as plasmapheresis or immunoglobulin, suppress the immune system and reduce inflammation caused by the immune system’s response to the disease. Either of these treatments can reduce ...

A patient from Reading who needed lifesaving treatment developed from blood plasma has thanked donors. Over the past three years, thousands of litres of blood from donors across England has been ...

A former musician with an autoimmune disease has welcomed the news that lifesaving medicines are now being made from Worcestershire donors.

The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.A recent comprehensive analysis of the Chronic ...

The GBS | CIDP Foundation International has unveiled survey data that paints a sobering picture of the physical, social, and financial challenges faced by individuals with Guillain-Barré Syndrome ...